Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Pharmacy (Basel, Switzerland)|July 21, 2021
Exercise and Worsening of Extrapyramidal Symptoms during Treatment with Long-Acting Injectable AntipsychoticsDavid D Kim, Donna J Lang, Darren E R Warburton, et al.
Clinical Schizophrenia & Related Psychoses|August 5, 2017
Exercise-associated extrapyramidal symptoms during treatment with long-acting injectable antipsychotic medications: A case reportDavid D Kim, Donna J Lang, Darren E R Warburton, et al.
Journal of Psychopharmacology (Oxford, England)|March 23, 2024
Impact of patient-specific factors on clozapine metabolism in individuals with treatment-resistant schizophrenia or schizoaffective disorderReza Rafizadeh, Anmol Sooch, Alessia Risi, et al.
Psychiatry Research|February 7, 2018
Reduced cardiovascular fitness associated with exposure to clozapine in individuals with chronic schizophreniaDavid D Kim, Donna J Lang, Ric M Procyshyn, et al.
Social Science & Medicine (1982)|December 31, 2024
Surviving the 2021 heat dome with schizophrenia: A qualitative, interview-based unpacking of risks and vulnerabilitiesLiv Yoon, Emily J Tetzlaff, Tiffany Chiu, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|July 5, 2017
Heart-rate response to alpha2-adrenergic receptor antagonism by antipsychoticsDavid D Kim, Donna J Lang, Darren E R Warburton, et al.
CNS Drugs|August 20, 2018
Antipsychotic-Associated Symptoms of Tourette Syndrome: A Systematic ReviewDavid D Kim, Alasdair M Barr, Yunsun Chung, et al.
The Clinical Neuropsychologist|November 30, 2019
Preliminary examination of the validity of the NIH toolbox cognition battery in treatment-resistant psychosisBriana D Cassetta, Mahesh Menon, Prescilla B Carrion, et al.
Pageof 3